179 related articles for article (PubMed ID: 699246)
1. Angiotensin converting enzyme inhibition in patients with congestive heart failure.
Gavras H; Faxon DP; Berkoben J; Brunner HR; Ryan TJ
Circulation; 1978 Nov; 58(5):770-6. PubMed ID: 699246
[TBL] [Abstract][Full Text] [Related]
2. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
3. Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.
Faxon DP; Creager MA; Halperin JL; Gavras H; Coffman JD; Ryan TJ
Circulation; 1980 May; 61(5):925-30. PubMed ID: 6153939
[No Abstract] [Full Text] [Related]
4. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
5. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
[TBL] [Abstract][Full Text] [Related]
7. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
Cohn JN; Levine TB
Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
[TBL] [Abstract][Full Text] [Related]
9. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.
Curtiss C; Cohn JN; Vrobel T; Franciosa JA
Circulation; 1978 Nov; 58(5):763-70. PubMed ID: 699245
[TBL] [Abstract][Full Text] [Related]
10. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
Benotti JR; Grossman W; Braunwald E; Carabello BA
Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
[TBL] [Abstract][Full Text] [Related]
11. The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease.
Faxon DP; Creager MA; Halperin JL; Sussman HA; Gavras H; Ryan TJ
Int J Cardiol; 1982; 2(2):251-62. PubMed ID: 6185446
[TBL] [Abstract][Full Text] [Related]
12. Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure.
Vrobel TR; Cohn JN
Am J Cardiol; 1980 Feb; 45(2):331-6. PubMed ID: 6153497
[No Abstract] [Full Text] [Related]
13. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension.
Gavras H; Flessas A; Ryan TJ; Brunner HR; Faxon DP; Gavras I
JAMA; 1977 Aug; 238(8):880-2. PubMed ID: 577978
[TBL] [Abstract][Full Text] [Related]
14. Drug suppression of the angiotensin system in congestive heart failure.
Sullivan JM
Annu Rev Med; 1983; 34():169-77. PubMed ID: 6190432
[TBL] [Abstract][Full Text] [Related]
15. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
Galie N; Branzi A; Magnani G; Melandri G; Caldarera I; Rapezzi C; Grattoni C; Magnani B
Cardiovasc Drugs Ther; 1993 Jun; 7(3):337-47. PubMed ID: 8364004
[TBL] [Abstract][Full Text] [Related]
16. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
Cody RJ; Covit AB; Schaer GL; Laragh JH
J Am Coll Cardiol; 1983 Apr; 1(4):1154-9. PubMed ID: 6187789
[TBL] [Abstract][Full Text] [Related]
18. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
Levine TB; Cohn JN
Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
[TBL] [Abstract][Full Text] [Related]
19. Role of the renin-angiotensin system in blood pressure regulation. The cardiovascular effects of converting enzyme inhibition in normotensive subjects.
Niarchos AP; Pickering TG; Case DB; Sullivan P; Laragh JH
Circ Res; 1979 Dec; 45(6):829-37. PubMed ID: 498446
[No Abstract] [Full Text] [Related]
20. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
Liang CS; Gavras H; Hood WB
J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
